{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:40:06Z","timestamp":1751053206301,"version":"3.41.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1023\/a:1020636002954","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T20:27:35Z","timestamp":1048019255000},"page":"181-182","source":"Crossref","is-referenced-by-count":4,"title":["New Treatments for Myocardial Fibrosis"],"prefix":"10.1007","volume":"16","author":[{"given":"John E.","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5100181_CR1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","volume":"16","author":"MA. Rossi","year":"1998","unstructured":"Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertension 1998;16:1031\u20131041.","journal-title":"J Hypertension"},{"key":"5100181_CR2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0022-2828(90)90079-H","volume":"22","author":"JE Bishop","year":"1990","unstructured":"Bishop JE, Greenbaum R, Gibson DG, Yacoub M, Laurent GJ. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol 1990;22:1157\u20131165.","journal-title":"J Mol Cell Cardiol"},{"key":"5100181_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1071-9164(99)90034-9","volume":"5","author":"S Wei","year":"1999","unstructured":"Wei S, Chow LTC, Shum OL, Qin L, Sanderson JE. J Cardiac Failure 1999;5:117\u2013126.","journal-title":"J Cardiac Failure"},{"key":"5100181_CR4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.CIR.102.12.1342","volume":"102","author":"KT. Weber","year":"2000","unstructured":"Weber KT. Targeting pathological remodeling. Concepts of cardioprotection and reparation. Circulation 2000;102:1342\u20131345.","journal-title":"Circulation"},{"key":"5100181_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(99)00021-8","volume":"42","author":"JE Bishop","year":"1999","unstructured":"Bishop JE, Lindahl G. Regulation of cardiovascular collagen synthesis by mechanical load. Cardiovasc Res 1999;42:27\u201344.","journal-title":"Cardiovasc Res"},{"key":"5100181_CR6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.CIR.98.17.1699","volume":"98","author":"DL Mann","year":"1998","unstructured":"Mann DL, Spinnale FG. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds. Circulation 1998;98:1699\u20131702.","journal-title":"Circulation"},{"key":"5100181_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/heart.86.6.701","volume":"86","author":"JE Sanderson","year":"2001","unstructured":"Sanderson JE, Lai KB, Shum IOL, Wei S, Chow LTC. Transforming growth factor-? expression in dilated cardiomyopathy. Heart 2001;86:701\u2013702.","journal-title":"Heart"},{"key":"5100181_CR8","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","volume":"99","author":"JR Silvestre","year":"1999","unstructured":"Silvestre JR, Heymes C, Oubenaissa A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999;99:2694\u20132701.","journal-title":"Circulation"},{"key":"5100181_CR9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","volume":"102","author":"CG Brilla","year":"2000","unstructured":"Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388\u20131393.","journal-title":"Circulation"},{"key":"5100181_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0735-1097(00)00671-9","volume":"36","author":"S Wei","year":"2000","unstructured":"Wei S, Chow LTC, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 2000;36:276\u2013281.","journal-title":"J Am Coll Cardiol"},{"key":"5100181_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005344-200201000-00009","volume":"39","author":"YT Sia","year":"2002","unstructured":"Sia YT, Parker TG, Tsoporis JN, Liu P, Adam A, Rouleau JL. Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat. J Cardiovasc Pharm 2002;39:73\u201387.","journal-title":"J Cardiovasc Pharm"},{"key":"5100181_CR12","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and rennin-angiotensin-aldosterone system. Circulation 1991;83:1849\u20131865.","journal-title":"Circulation"},{"key":"5100181_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/oxfordjournals.eurheartj.a014771","volume":"17","author":"JE Sanderson","year":"1996","unstructured":"Sanderson JE, Cockram CS, Yu CM, Campbell SE, Weber KT. Myocardial fibrosis and hyperaldosteronism. Eur Heart J 1996;17:1761\u20131762.","journal-title":"Eur Heart J"},{"key":"5100181_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"5100181_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1020640203862","volume":"163","author":"A Cittadini","year":"2002","unstructured":"Cittadini A, Casaburi C, Monti MG, et al. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure. Cardiovasc Drugs Ther 2002;16(3):195\u2013202.","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020636002954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020636002954\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020636002954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:06:44Z","timestamp":1751051204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020636002954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["5100181"],"URL":"https:\/\/doi.org\/10.1023\/a:1020636002954","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}